These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy. Hassan JM; Cookson MS; Smith JA; Johnson DL; Chang SS J Urol; 2004 Sep; 172(3):882-4. PubMed ID: 15310989 [TBL] [Abstract][Full Text] [Related]
25. [Recurrence of bladder cancer in fossa navicularis 12 years after total cystectomy: a case report]. Takao T; Takada S; Sugao H; Osafune M Hinyokika Kiyo; 1999 Dec; 45(12):851-3. PubMed ID: 10659421 [TBL] [Abstract][Full Text] [Related]
26. [Recurrence of bladder cancer in fossa navicularis 17 months after cystourethrectomy: a case report]. Nakane K; Katoh T; Yokoi S; Ehara H; Takahashi Y; Ishihara S; Deguchi T Hinyokika Kiyo; 2005 Sep; 51(9):631-3. PubMed ID: 16229378 [TBL] [Abstract][Full Text] [Related]
27. Carcinoma-in-situ of the urothelium. Daly JJ Urol Clin North Am; 1976 Feb; 3(1):87-105. PubMed ID: 936371 [No Abstract] [Full Text] [Related]
28. Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature. Stein JP; Penson DF; Wu SD; Skinner DG J Urol; 2007 Sep; 178(3 Pt 1):756-60. PubMed ID: 17631333 [TBL] [Abstract][Full Text] [Related]
29. Intravesical instillations with bacillus calmette-guérin for the treatment of carcinoma in situ involving prostatic ducts. Palou Redorta J; Schatteman P; Huguet Pérez J; Segarra Tomás J; Rosales Bordes A; Algaba F; Villavicencio Mavrich H Eur Urol; 2006 May; 49(5):834-8; discussion 838. PubMed ID: 16426729 [TBL] [Abstract][Full Text] [Related]
30. Increased infiltration of tumor associated macrophages is associated with poor prognosis of bladder carcinoma in situ after intravesical bacillus Calmette-Guerin instillation. Takayama H; Nishimura K; Tsujimura A; Nakai Y; Nakayama M; Aozasa K; Okuyama A; Nonomura N J Urol; 2009 Apr; 181(4):1894-900. PubMed ID: 19237175 [TBL] [Abstract][Full Text] [Related]
31. Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection. Holzbeierlein JM; Lopez-Corona E; Bochner BH; Herr HW; Donat SM; Russo P; Dalbagni G; Sogani PC J Urol; 2004 Sep; 172(3):878-81. PubMed ID: 15310988 [TBL] [Abstract][Full Text] [Related]
32. Prophylactic urethrectomy in male patients with bladder cancer. Stams UK; Gursel EO; Veenema RJ J Urol; 1974 Feb; 111(2):177-9. PubMed ID: 4810759 [No Abstract] [Full Text] [Related]
33. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy. Shariat SF; Palapattu GS; Karakiewicz PI; Rogers CG; Vazina A; Bastian PJ; Schoenberg MP; Lerner SP; Sagalowsky AI; Lotan Y Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114 [TBL] [Abstract][Full Text] [Related]
38. Carcinoma in situ developing in an ileal neobladder. Ide H; Kikuchi E; Shinoda K; Mukai M; Murai M Urology; 2007 Mar; 69(3):576.e9-11. PubMed ID: 17382181 [TBL] [Abstract][Full Text] [Related]
39. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder. Cho KS; Seo JW; Park SJ; Lee YH; Choi YD; Cho NH; Yang SC; Hong SJ Urol Int; 2009; 82(3):306-11. PubMed ID: 19440019 [TBL] [Abstract][Full Text] [Related]
40. [Diagnosis, prognosis and therapeutic results in urothelial dysplasia in patients with bladder cancer]. Csapó Z; Kolozsy Z; Dauda G; Mohácsi L Orv Hetil; 1984 Jul; 125(31):1875-8, 1881. PubMed ID: 6472835 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]